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Abstract
Background/Aims: We showed that patho-physiological concentrations of either 7-keto-
cholesterol (7-KC), or cholestane-3beta, 5alpha, 6beta-triol (TRIOL) caused the eryptotic 
death of human red blood cells (RBC), strictly dependent on the early production of reactive 
oxygen species (ROS). The goal of the current study was to assess the contribution of the 
erythrocyte ROS-generating enzymes, NADPH oxidase (RBC-NOX), nitric oxide synthase 
(RBC-NOS) and xanthine oxido-reductase (XOR) to the oxysterol-dependent eryptosis and 
pertinent activation pathways. Methods: Phosphatidylserine exposure at the cell surface was 
estimated from annexin-V-binding, reactive oxygen/nitrogen species (RONS) and nitric oxide 
formation from 2’,7’-dichloro-dihydrofluorescein (DCF-DA) and 4-amino-5-methylamino-
2’,7’-difluorofluorescein diacetate (DAF-FM DA) -dependent fluorescence, respectively; Akt1, 
phospho-NOS3 Ser1177, and PKCζ from Western blot analysis. The activity of individual 7-KC 
(7 μM) and TRIOL (2 μM) on ROS-generating enzymes and relevant activation pathways was 
assayed in the presence of Diphenylene iodonium chloride (DPI), N-nitro-L-arginine methyl 
ester (L-NAME), allopurinol, NSC23766 and LY294002, inhibitors in this order of RBC-NOX, 
RBC-NOS, XOR and upstream regulatory proteins Rac GTPase and phosphoinositide3 Kinase 
(PI3K); hemoglobin oxidation from spectrophotometric analysis. Results: RBC-NOX was the 
target of 7-KC, through a signaling including Rac GTPase and PKCζ, whereas TRIOL caused 
activation of RBC-NOS according to the pathway PI3K/Akt, with the concurrent activity of 
a Rac-GTPase. In concomitance with the TRIOL-induced .NO production, formation of 
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methemoglobin with global loss of heme were observed, ascribable to nitrosative stress. 
XOR, activated after modification of the redox environment by either RBC-NOX or RBC-
NOS activity, concurred to the overall oxidative/nitrosative stress by either oxysterols. When 
7-KC and TRIOL were combined, they acted independently and their effect on ROS/RONS 
production and PS exposure appeared the result of the effects of the oxysterols on RBC-
NOX and RBC-NOS. Conclusion: Eryptosis of human RBCs may be caused by either 7-KC or 
TRIOL by oxidative/nitrosative stress through distinct signaling cascades activating RBC-NOX 
and RBC-NOS, respectively, with the complementary activity of XOR; when combined, the 
oxysterols act independently and both concur to the final eryptotic effect.
IntroductionOxysterols, long time known as products of cholesterol metabolism, attracted much interest when it was suggested their involvement in the pathogenetic mechanisms supporting 
inflammation-driven pathologies like cancer, atherosclerosis and neurodegenerative 
disorders [1-3]. Cytotoxicity of these compounds, among which 7-hydroxy-, 7-keto- 
cholesterol (7-KC) and cholestane-3beta, 5alpha, 6beta-triol (TRIOL) are considered among 
the most toxic members [4], has been reported in various cells, including smooth muscle, 
endothelial, monocytic, and enterocytic ones [5-10]. Oxysterols cause extensive generation of 
reactive oxygen species through up-regulation of NADPH oxidase (NOX) family enzymes [11], 
a main source of cellular ROS. In accordance, the oxysterol toxicity includes the induction of 
cell death (apoptosis and/or oncosis), inflammatory activities, phospholipidosis, variations of cytoplasmatic levels of calcium, mitochondrial and microsomal membrane perturbations, 
and polyamine metabolism [12], all conditions that share the intracellular overproduction 
of reactive oxidants.
Injury to circulating erythrocytes, including oxidative stress, could trigger their suicidal death or eryptosis, a process typically associated with increase of intracellular calcium, 
membrane scrambling, with phosphatidylserine (PS) exposure, and cell shrinkage [13]. We have recently demonstrated that a mixture of oxysterols, consistent with the oxysterol 
pool in the plasma of hyper-cholesterolemic subjects [14], caused eryptosis of healthy 
human red blood cells [15]. The oxysterol-stimulated eryptosis was strictly dependent on the early generation of reactive oxygen species and occurred even in the virtual absence of 
calcium [15]. Quite consistently with their reported toxicity [4], only the 7-KC and TRIOL 
components of the mixture had appeared individually active. Both oxysterols caused early production of reactive oxygen species, followed by prostaglandin E2 biosynthesis, calcium 
influx, and inhibition of the amino-phospholipid translocase (APTL). However, TRIOL only 
caused hemolysis, providing evidence of some additional mechanism of cell damage [15].
Due to loss of protein expression during RBC maturation, the oxysterol-triggered 
oxidative stress-dependent eryptosis should basically rely on either direct or indirect acute 
activation of enzymes that generate reactive either oxygen or nitrogen species (RONS). 
In addition to NOX isoforms (RBC-NOX) [16], the activity of the erythrocyte nitric oxide 
synthase (RBC-NOS) [17], and of xanthine oxido-reductase (XOR) [18] have to be considered. 
Moreover, the activity of oxysterols in red blood cells might influence the hemoglobin (HbO2) 
autoxidation reactions [19]. The aim of the study is investigating the extent to which the 
ROS-generating enzymes are involved in the eryptosis induced by patho-physiological 
concentrations of either 7-KC or TRIOL, as well as upstream signaling pathways leading to 
activation of these enzymes. The effect of the oxysterols on the hemoglobin oxidative status 
is also being considered. Finally, the activity of the combined oxysterols has been explored.
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Materials and Methods
7-Ketocholesterol (7-KC) and cholestan-3β,5α,6β-triol (TRIOL) were purchased from Avanti Polar 
Lipids, Inc (Alabaster, AL, USA). All other reagents and chemicals were from Sigma-Aldrich Chemical Co (St. 
Louis, MO, USA), unless indicated.
Red blood cells and treatment
Blood was drawn from healthy volunteers, with informed consent, and RBCs immediately isolated by a 
20 min centrifugation at 2 000 g, 4 °C, over Ficoll (Biochrom KG, Berlin, Germany). RBCs (0.4 % hematocrit) 
were incubated at 37°C, 5% CO2 and 95% humidity, in Ringer solution containing (mM) 125 NaCl, 5 KCl, 1 
MgSO4, 32 N-2-hydroxyethylpiperazine-N-2-ethanesulfonic acid (HEPES)/NaOH, 5 glucose, 1 CaCl2, pH 7.4, 
for the indicated time. 7-KC and TRIOL were added in a final 0.1% (v:v) tetrahydrofuran (THF) concentration. 
Preliminary experiments showed that THF did not have any effect under this condition, therefore control 
RBCs were incubated with THF.
Where indicated, pre-treatment with NADPH oxidase inhibitor Diphenyleneiodonium (DPI, 10μM), 
Rac1 inhibitor [(N(6)-[2-[[4-(diethylamino)-1-methylbutyl]amino]-6-methyl-4-pyrimidinyl]-2-methyl-4,6-
quinolinediamine trihydrochloride] ) (NSC23766, 500μM), NOS inhibitor Nω-Nitro-L-arginine methyl ester 
hydrochloride (L-NAME,100μM), phosphatidylinositol 3-kinase inhibitor (2-(4-morphlinyl)-8-phenyl-4H-1-
benzopyran-4-one) (LY294002, 20μM) or L-arginine (5 mM) was done for 1 h before adding the oxysterols. 
Control RBCs were pre-incubated with only vehicle in these assays.
Measurement of phosphatidylserine (PS) externalization and forward scatter
RBCs were washed once in phosphate buffered saline, pH 7.4 (PBS) and adjusted at 1.0x106 cells/mL 
with combining buffer according to the manufacturer’s instructions (eBioscience Inc., San Diego, CA, USA, 
88-8005). Cell suspension (100 μL) was added to a new tube and incubated with 5 μL Annexin V-FITC, at 
room temperature in the dark for 15 min. Then samples of at least 1x104 cells were subjected to fluorescence-
activated cell sorting (FACS) analysis by Epics XL™ flow cytometer, using Expo32 software (Beckman Coulter, 
Fullerton, CA). Cells were analyzed by forward scatter, and annexinV-fluorescence intensity was measured 
in fluorescence channel FL-1 with an excitation wavelength of 488 nm and an emission wavelength of 530 
nm.
Measurement of intracellular oxidant species
The RONS or .NO levels were monitored by measuring the fluorescence changes resulting from oxidation 
of dichloro-dihydro-fluorescein diacetate (DCF-DA) or 4-amino-5-methylamino-2’,7’-difluorofluorescein 
diacetate (DAF-FM DA), respectively. Fluorescence probe, at 10 μM final concentration, was added to the 
cell medium 30 min before the end of treatment in the dark. Cells were collected by centrifugation (2 000 
g, 4°C, 5 min), washed, suspended in PBS and subjected to FACS analysis. At least 1x104 cells were analyzed 
for each sample.
Western blot analysis
RBCs were washed with PBS twice, resuspended in lysis buffer (20 mM Tris-HCl, pH 7.6, 100 mM 
NaCl, 10 mM MgCl2, 2 mM PMSF, 0.5 mM DTT, 2 mg/mL Lysozyme) with protease inhibitor cocktail (Roche 
Applied Science, Indianapolis, IN, 11836170001) and sonicated for 60 s on ice with Labsonic LBS1-10 (Falc 
Instruments srl. Treviglio, BG, Italy). After centrifugation at 100 000 g for 1 h at 4°C, upper-half supernatant 
was collected as a cytosolic fraction. When required, the pellets were resuspended in the cold lysis buffer 
containing 1% Triton X-100. Samples were sonicated for 30 s and centrifuged again. The supernatant was 
collected as a membrane fraction.
The protein concentration of each sample was determined by using the Bradford protein assay 
reagent (Bio-Rad, Hercules, CA, USA). Protein samples (50 μg/line) were separated on 10% SDS-PAGE and 
transferred to nitrocellulose membrane. The immunoblot was incubated overnight at 4°C with blocking 
solution (5% skimmed milk), followed by incubation with the following monoclonal antibodies (Santa Cruz 
Biotechnology, Dallas, TX, USA) for 1 h at room temperature (Table 1).
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Blots were washed two times with 
Tween 20/Tris-buffered saline and 
incubated with a 1:2000 dilution of 
horseradish peroxidase-conjugated anti-
IgG antibody (Dako, Santa Clara, CA, USA) 
for 1 h at room temperature. Blots were 
again washed five times with Tween 20/
Tris-buffered saline and then developed by 
enhanced chemiluminescence (Amersham 
Life Science, Little Chalfont, UK). Immunoreactions were also performed using anti-β-actin monoclonal 
antibody (clone C4, catalogue no. Sc-47778; Santa Cruz Biotech) as loading controls.
Measurement of hemoglobin oxidation
RBCs from a 5-mL incubation mixture were collected by centrifugation, resuspended in 2 mL of 
hypotonic phosphate buffer (5 mM, pH 7.4), lysed by sonication as above reported and precipitated. Aliquots 
of supernatant in a final volume of 1.0 mL of PBS were scanned at 500–700 nm (DU-640 Beckman, Brea, 
CA, USA) and concentrations of the oxidation products of hemoglobin (Hb) in mixtures of HbO2, met-Hb 
and hemichrome were calculated according to Winterbourn [20]. To assess heme loss, the samples were 
then supplemented with 0.1% KCN and 0.1% K
3
Fe(CN)
6
 to convert all Hb species to a complex with CN-, 
which absorbs at 408 nm (Soret’s band). Heme loss was calculated by the difference in absorbance with 
erythrocyte incubated in the absence of oxysterol (control) and processed similarly.
Results and Discussion
High plasma levels of oxysterols, including the highly toxic 7-KC and TRIOL, concur to 
tissue damage in hypercholesterolemia. We have recently shown that both oxysterols, at the concentrations consistent with the amounts measured in hypercholesterolemic plasma, possess a remarkable eryptotic activity, strictly dependent on the early generation of oxidant 
species, according to a calcium-independent mechanism [15]. Presence and activity of 
NOX isoforms [16], endothelial-type NOS [17] and XOR [18] have been reported in human 
erythrocytes as a source of reactive oxygen/nitrogen species (RONS). The selective inhibition 
of these enzymes and of a number of activating factors upstream, matched with the exposure 
of RBCs to the individual 7-KC or TRIOL assayed at concentrations of patho-physiological 
interest (7 μM and 2 μM, respectively) [14], has been used as a strategy to investigate to what 
extent these enzymes are involved in the toxicity of the oxysterols in red blood cells. RONS 
production and PS exposure have been considered as a probe for the eryptotic activity.
7-KC activates RBC-NOX
The seven NOX/DUOX family enzymes are variously distributed in cells and tissues and 
finely regulated. With the exception of NOX-4 and the calcium-dependent NOX-5, the trans-
membrane catalytic subunits of NADPH oxidase isozymes, namely NOX -1, -2 and -3, require 
the interaction with cytosolic regulatory subunits, among which a Rac GTPase is a critical 
activator [21, 22]. The NOX activity described in human RBCs, is apparently due to the 
isozymes NOX-1 and NOX-5, with NOX-2 and NOX-4 minor components [16]. To investigate 
the role of RBC-NOX in the eryptosis triggered by 7-KC- or TRIOL, freshly isolated human 
erythrocytes were pre-incubated with either DPI, an inhibitor of the FAD-reducing activity 
of the gp91-like catalytic subunit of all NADPH oxidase isoforms, or NSC23766, a specific 
inhibitor of the Rac-family GTPases, before incubating with either oxysterols. We observed 
that the 7-KC-induced increase of both DCF-DA fluorescent oxidant species and PS exposure 
were completely prevented by either DPI or NSC23766, demonstrating the dependence of 
the 7-KC-induced eryptosis on the RBC-NOX and Rac-GTPase activity (Fig. 1A, B).
Table 1. Antibodies
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The pre-incubation of the cells with DPI did not affect the production of DCF-DA 
fluorescent oxidants and the subsequent PS scrambling induced by TRIOL treatment; 
instead, pre-incubation with NSC23766 inhibited the TRIOL-induced DCFDA-associated 
fluorescence by 27%, without affecting the PS exposure (Fig. 1A, B). Collectively, these results 
underscored the importance of a Rac-GTPase in the generation of oxidants by TRIOL, which 
however appeared independent of NOX.
The protein kinase C (PKC) plays a role in the activation of NOX in many cell types [23] 
and modulates a number of events in RBCs including membrane scrambling [24]. There 
is evidence that various PKC isoforms are expressed in human erythrocytes, including 
the atypical calcium-independent PKCζ and PKCζ [25]. The translocation from cytosol to 
membrane is crucial for the activation of PKC, including PKCζ [26, 27]. Western blot analysis 
of PKCζ in RBCs treated for 1 h with oxysterols showed that 7-KC, but not TRIOL, induced 
migration of the enzyme in the membrane (Fig. 1C). Therefore, in harmony with our previous 
study which indicated a role for atypical PKC isoform(s) in the generation of reactive species 
and eryptotic activity of 7-KC [15], present findings that identify PKCζ in the RBC membrane, 
Fig. 1. 7-Ketocholesterol activates RBC-NOX through PKCζ-RacGTPase signaling pathway. Effect of NOX 
inhibitor DPI or Rac GTP specific inhibitor NSC23766 on the oxysterol-induced RONS formation (A), PS-
externalization (B), and PKCζ translocation to membrane (C). RBCs were pre-incubated for 1h with inhibitor 
or vehicle before adding the oxysterol. RBCs were lysed after 1 h of incubation for Western blot detection 
of PKCζ, while were left to incubate for 2 h or 24 h before the cytofluorimetric measure of DCF-associated 
MFI (mean fluorescence intensity) and AnnexinV-FITC associated cell fluorescence, respectively. Data are 
the means±SD of six (A and B) or three (C) separate experiments with a representative image. *Significantly 
different vs control (P<0.0001); § significantly different vs samples of the relevant group pre-incubated in 
the absence of inhibitor (P<0.0001) (one-way Anova associated with Bonferroni’s post hoc test).
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point to the activation of this enzyme and suggest that PKCζ is part of the 7-KC-dependent 
signaling pathway leading to RBC-NOX activation.
The activity of Ca+2-independent PKCs, including PKCζ is regulated by interaction with 
protein scaffolds [26, 28]. Our and other studies [29] reporting that 7-KC activates PKCζ may 
be expressive of a unique location of 7-KC [30], possibly within membrane microdomains 
that control binding to specific scaffolds and enzyme activation. Interestingly, a membrane-
active compound such as lysophosphatidic acid, that modulates the organization of lipid 
bilayers [31], has been shown to activate PKCζ in human red blood cells [32]. On the other 
hand, we observed that TRIOL, whose position in membrane bilayers is remarkably different 
from that of 7-KC [33, 34], did not induce activation of PKCζ (Fig. 1C).
Rac activation by either calcium-dependent or atypical PKCs has been reported in 
various cells in pathways other than NOX activation [35-37]. On the contrary, membrane translocation and activation of PKCζ was prevented by inhibiting Rho-GTPase [38], showing 
that PKCΖ can be a downstream effector of Rho-GTPase signaling pathways. To position 
PKCζ in the 7-KC signaling pathway, we looked at the 7-KC-stimulated activation of PKCζ in 
the presence of NSC23766. Pre-treatment of RBCs with the Rac inhibitor did not affect the 
translocation of the kinase in the membrane (Fig. 1C), indicating that the 7-KC-stimulated 
membrane targeting of PKCζ did not require, and occurred independently of, Rac activation. 
In other words, PKCζ may be positioned upstream or in parallel to Rac in the 7-KC-stimulated 
signaling leading to RBC-NOX activation. A RBC-NOX activation pathway where a Rac protein 
is activated by a calcium-dependent PKC has been suggested to be working in sickle cells 
[16]. It is tempting to speculate that atypical PKCs such as PKCζ may perform an equivalent 
function in regulating Rac where intracellular calcium is not critical for activation.
TRIOL activates RBC-NOS
Red blood cells express a functional nitric oxide synthase, isoform 3, localized on the 
cytoplasmic side of the RBC membrane [17]. To study the involvement of RBC-NOS in the 
oxysterol-induced eryptosis, RBCs were pre-incubated with either L-NAME or L-arginine, a 
NOS inhibitor and activator, respectively. Neither L-NAME nor L-arginine significantly varied 
the DCF-DA associated-fluorescence and the extent of PS exposure induced by 7-KC (Fig. 
2A, B), indicating that RBC-NOS was not involved with the 7-KC activity. By contrast, pre-
incubation with L-NAME abrogated the TRIOL-induced RONS production and PS exposure, 
whereas pre-incubation with L-arginine caused overproduction of RONS and increased the 
eryptotic activity of the oxysterol (Fig. 2A, B). Moreover, when RBCs were loaded with DAF-
FM diacetate, a probe for intracellular .NO, fluorescent signals through flow cytometry were 
detected solely in the TRIOL-treated RBCs (Fig. 2C).
RBC-NOS may be controlled by interactions with regulatory proteins and 
phosphorylation of various serine, threonine and tyrosine residues [17, 39, 40]. In particular, 
the enzyme is activated by phosphorylation of its Ser1177 by Akt, the activation of which 
is mediated by PI3K [17, 40]. The phosphorylation degree of Akt (pAkt) and RBC-NOS 
(p-NOS1177) were assessed by immunoblot analysis after a 1 h treatment of RBCs with the 
oxysterols. In comparison with untreated RBCs (control), the incubation in the presence of 
TRIOL resulted in a net increment of both pAkt and p-NOS1177 (Fig. 2D). Moreover, LY294002, 
a specific PI3K inhibitor, completely prevented the TRIOL-induced phosphorylation of Akt 
and RBC-NOS (Fig. 2D), as further indication of the functional association between TRIOL 
and the PI3K/Akt signaling axis. Consistently with the above-reported findings (Fig. 2A, B), 
7-KC did not promote phosphorylation of neither enzyme (Fig. 2D).
We observed that the PI3K inhibitor LY294002, caused a significant reduction but 
did not abrogate the DAF-FM fluorescence associated with RBCs treated with TRIOL (Fig. 
3), which suggested a parallel activation pathway for RBC-NOS. The simultaneous use of 
LY294002 and the Rac inhibitor NSC23766 completely prevented the appearance of the 
DAF-FM fluorescence associated with TRIOL-treated RBCs (Fig. 3), providing evidence of a 
dual regulation of the enzyme. Therefore, consistent with the complementary experiments 
described in Fig. 1 (A, B), these findings show that a Rac protein is involved in the TRIOL-
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Fig. 2. TRIOL activates RBC-NOS through PI3P kinase-Akt signaling axis. Effect of NOS inhibitor L-NAME or 
activator L-arginine on the oxysterol-induced RONS formation (A) and  PS-externalization (B). Arithmetic 
means±SD (n=6) of DCF-associated MFI (mean fluorescence intensity) and AnnexinV-FITC associated cell 
fluorescence measured after a 2 h or 24 h incubation, respectively, incubation of RBCs with oxysterol, 
preceded by 1 h pre-treatment in the presence of inhibitor, stimulant or vehicle. (C) DAF-FM associated 
fluorescence in RBCs treated with oxysterols. RBCs were loaded with DAF-FM diacetate and incubated 
for 2 h in the absence (control) or in the presence of oxysterols. Imagine representative of three separate 
experiments carried out in duplicate with comparable results. (D) Western blot analysis with densitometric 
analysis of proteins from RBCs incubated for 1h with vehicle (control) or oxysterols (columns 2,4) or pre-
treated for 1 h with LY294002 before 1 h incubation with TRIOL (column 3). b-actin was used as the internal 
control. Imagine representative of four separate experiments. *Significantly different vs control (P<0.0001); 
§ significantly different vs samples of the relevant group pre-incubated in the absence of inhibitor (P<0.0001) 
(one-way Anova associated with Bonferroni’s post test).
Cell Physiol Biochem 2019;53:933-947
DOI: 10.33594/000000186
Published online: 6 December 2019 940
Cellular Physiology 
and Biochemistry
© 2019 The Author(s). Published by 
Cell Physiol Biochem Press GmbH&Co. KG
Attanzio et al.: Eryptotic Oxysterols Activate Erythrocytes NADPH Oxidase and Nitric 
Oxide Synthase
induced RBC-NOS activation and .NO production in the erythrocytes. The PI3K /Akt dependent 
activation of eNOS in response to TRIOL has been shown in endothelial cells [41]. We report 
here for the first time that TRIOL stimulates phosphorylation and activation of both Akt and 
RBC-NOS in a PI3K-dependent manner in red blood cells, and that a Rac-GTPase contributes 
to the whole TRIOL-dependent RBC-NOS activation.
The production of .NO in the presence of the PI3K inhibitor suggests that the TRIOL-
stimulated Rac-GTPase activates a non-phosphorylated RBC-NOS. In line with our findings, 
other studies reported that physical interactions between NOX-coupled Rac-GTPases and 
various NOS isoforms result in enzyme activation [42-45]. Co-regulation of the constitutive 
NOS and NOX by the GTPase Rac-1 has been shown in endothelial cells [46]. In apparent 
contrast with this finding, we found that the erythrocytes exposed to 7-KC did not generate 
reactive species when pre-incubated with DPI, a NOX inhibitor working downstream of Rac 
activation, suggesting that the 7-KC-activated Rac- GTPase had not stimulated the activity of 
RBC-NOS. Alternatively, chemico-physical changes to the RBC membrane imposed by 7-KC, 
but not TRIOL [30, 34], may have prevented interactions between the same Rac-GTPase and 
RBC-NOS. That the Rac-1 activity may be regulated by shear stress and variations of the 
membrane fluidity [47, 48] could provide some support to this hypothesis.
TRIOL causes Hb oxidation and loss of heme
The continuous autoxidation of HbO2 to generate Met-Hb and O2.- is the most abundant 
source of reactive species in red blood cells, controlled by superoxide dismutase (SOD) 
and specific reductases [49]. We investigated whether either 7-KC or TRIOL affected the 
Hb autoxidation. Spectral changes at 560, 577 and 630 nm were analyzed to assess the 
oxidation status of hemoglobin in RBCs incubated either in the absence (control) or in the 
presence of oxysterols. Table 2 reports the levels of HbO2, MetHb and hemichrome, as well as the amount of heme, measured in the cells after a 24 h incubation in the presence of either 
7-KC or TRIOL. 7-KC did not modify the total amount nor the oxidation status of hemoglobin 
with respect to control RBCs. TRIOL, instead, caused spectral changes indicating a significant 
decrease of HbO2 with a concomitant increase of MetHb (Table 2). Formation of hemichrome 
was not evident, whereas a loss of heme was observed after TRIOL incubation (Table 2), a 
finding consistent with the reported hemolytic effect of this oxysterol [15]. While showing 
that 7-KC did not induce changes to the redox equilibrium of Hb, these findings suggested 
the involvement of RBC-NOS-derived oxidants.
The human RBC-NOS is almost inactive under physiological conditions [50]. Fluctuating 
and reversible activation of the enzyme by physiological stimuli such as an increase of 
Fig. 3. Simultaneous inhibition of PI3P kinase and Rac GTPase abrogates the TRIOL-induced NO. formation 
in RBCs. DAF-FM associated cell fluorescence measured after a 2 h incubation of RBCs with TRIOL (2 µM) 
preceded by 1 h pre-treatment in the absence or in the presence of LY294002 (20 µM) or LY294002 (20 µM) 
plus NSC23766 (500 µM). Imagine representative of three separate experiments carried out in duplicate 
with comparable results.
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shear stress, can cause release of moderate amounts of .NO [50, 51] supposed escaping 
irreversible dioxygenation reaction with HbO2, and being of patho-physiological relevance for 
cardiovascular protection [50]. Interestingly, small amounts of .NO prevents, whereas excess 
stimulate eryptosis [52]. Indeed, a quite different scenery can be established as a result of 
.NO over-production. .NO may prompt Hb autoxidation by combining spontaneously with O2.- 
at diffusion-controlled rate, even in the presence of SOD [49, 53]. This in turn causes increase 
of MetHb and generates peroxynitrite [50], a powerful oxidant and nitrating agent [54], 
whose activity can finally support the eryptosis. The amino-phospholipid translocase, whose 
inhibition has appeared a key event in the oxysterol-triggered PS exposure [15], is inhibited 
by products from cellular oxidation such as lipoperoxides [15, 55] and by nitrosative stress 
[56]. In addition, oxy- deoxy- and met-Hb can effectively scavenge .NO as well as peroxynitrite 
[57-59], with formation of nitrosylated and oxidized species and final accumulation of met-
Hb [58, 60]. Finally, .NO overproduction and damage to membrane proteins may account 
for the observed loss of heme. Peroxynitrite-induced hemolysis of human red blood cells 
has been reported [61] and shear stress, which is known to activate RBC-NOS [62], results 
in hemolysis when cells are exposed to repeated and supra-physiological shear stress 
conditions [63].
7-KC, TRIOL and XOR
The pre-incubation of red blood cells with the inhibitor allopurinol significantly 
reduced by 20% the DCF-DA associated-fluorescence caused by treatment with 7-KC or 
TRIOL, indicating some contribution of the xanthine oxido-reductase to the activity of either 
oxysterols (Fig. 4). The observation that the 7-KC- or TRIOL- dependent production of 
reactive species did not occur in the presence of DPI or L-Name, respectively, implicated that 
only RBC-NOX and RBC-NOS were activated by the oxysterols. These data that unmasked the 
contribution of the XOR to the overall generation of oxidative stress show that, under our 
conditions, the activity of XOR is subordinate to the activity of either RBC-NOX or RBC-NOS. 
Our evidence suggests that oxidants from either enzyme activity can promote the conversion 
of the NAD-reducing xanthine-dehydrogenase in the O2-reducing -oxidase, thus generating 
superoxide anion and hydrogen peroxide [64, 65].
The combination of 7-KC and TRIOL brings about concurrent activation of RBC-NOX and 
RBC-NOS
The circulating oxysterols may be supposed to act simultaneously on red blood cells. This 
prompted us to assess whether and/or to what extent the oxysterol toxicity, in terms of ROS/
RONS production and eryptotic response changed when patho-physiological amounts of 7-KC 
and TRIOL acted in combination, with respect to the individual compounds. Measurements 
were then performed in the presence of both oxysterols, without or with pre-incubation of 
the erythrocytes with either DPI or L-NAME. The generation of DCF-DA fluorescent oxidant 
species observed in cells treated with 7-KC and TRIOL was significantly higher than that measured in the presence of the individual oxysterols, whereas .NO formation was consistent 
with that observed in the presence of TRIOL alone (Fig. 5). In comparison with erythrocytes 
incubated with both 7-KC and TRIOL, the pre-incubation of the cells with L-NAME remarkably 
Table 2. Oxidation status of hemoglobin (Hb) and heme content in oxysterol-treated RBCs. Values are the 
mean±SD of five separate experiments. Means in the same column with different superscript
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inhibited the DCF-DA fluorescence by 38%, and abolished .NO production, whereas pre-
incubation with DPI resulted in a decrease of DCF-DA fluorescent oxidants of over 30%, however the .NO formed was unmodified (Fig. 5). Finally, pre-incubation with both inhibitors 
completely abolished the generation of DCF-DA fluorescent oxidant species and .NO (Fig. 5). 
These findings showed that, under the considered conditions, RBC-NOX and RBC-NOS can be 
activated simultaneously and independently by the combined 7-KC and TRIOL.
The number of Annexin V-binding cells after incubation with 7-KC and TRIOL was 
significantly higher than measured in the presence of the single oxysterols; in addition, the 
amount of PS exposed to the surface of the erythrocytes treated with both oxysterols was 
reduced by 30% and 32% by the pre-incubation with either L-NAME or DPI, respectively, 
and was annulled by the concurrent presence of the inhibitors (Fig. 5).
Therefore, according to our data, 7-KC and TRIOL do not interfere each other in causing 
activation of RBC-NOX and RBC-NOS, respectively, and production of ROS/RONS. As a 
result of their combination, DCF-DA fluorescent compounds appear to be generated to an 
approximately equivalent extent by the activity of RBC-NOX and RBC-NOS. Then the oxidative 
stress and the eryptotic response resulting from the combined action of 7-KC and TRIOL in red blood cells may be considered as the consequence of the effect of both oxysterols on 
RBC-NOX and RBC-NOS. These results extend our previous studies regarding eryptosis in red 
blood cells exposed to a mixture of oxysterols, including 7-KC and TRIOL, or incubated with 
healthy human blood spiked with the mixture, to simulate a patho-physiologic condition 
of hypercholesterolemia [15]. In this context our findings concur to explain the increase in 
eryptosis recently reported in dyslipidemic patients [66].
Fig. 4. Inhibition of XOR by allopurinol partially inhibits RONS production triggered by both7-KC and TRIOL. 
DCF-DA associated cell fluorescence measured after a 2 h incubation of RBCs with TRIOL or 7-KC preceded 
by 1 h pre-treatment in the absence or in the presence of  allopurinol (500 µM). Imagine representative of 
three separate experiments carried out in duplicate with comparable results.
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Conclusion
Our study shows that patho-physiological amounts of either 7-KC or TRIOL induce 
oxidative stress-dependent eryptosis by different mechanisms and distinct molecular 
pathways. The 7-KC activity is mediated by RBC-NOX activation, dependent on Rac-GTPase- 
and PKCζ, whereas that of TRIOL by RBC-NOS through the PI3K/Akt pathway, with the 
additional stimulation of the enzyme by a Rac-GTPase. A complementary activity of XOR 
is common to the full effect of both oxysterols. The TRIOL-induced nitrosative stress may 
rationalize Hb oxidation with MetHb accumulation, and possibly membrane damage with 
heme loss. Concurrent activity of RBC-NOX and RBC-NOS, and ROS/RONS production, 
can bring about eryptosis when 7-KC and TRIOL act in combination, as can occur in 
hypercholesterolemia.
Oxysterols are acknowledged to induce ROS generation by up-regulating NADPH 
oxidase, our findings show direct enzyme activation through tightly coupled molecular 
events at the level of plasma membrane. Many of the biological activities of oxysterols may be based on their biophysical properties and interaction with membrane lipid and/or protein 
components [33, 34]. In this context, with the present knowledge that RBC-NOX and RBC-NOS 
can be activated by physical and mechanical forces on the membrane [62, 67, 68] it is quite 
reasonable to hypothesize that 7-KC and TRIOL cause activation of these enzymes through 
physico-chemical alterations of the membrane moiety. Functional organization of the two 
oxysterols and their effectors at different membrane micro-domains [34] may be essential to 
activate separately RBC-NOX and RBC-NOS [69-71]. However, the molecular mechanism(s) 
that allow 7-KC and TRIOL, either alone or in combination, a selective activation of specific 
proteins of distinct signaling-pathways in red blood cells remain open to future studies.
Fig. 5. Combination 
of 7-KC and TRIOL induces independent 
activation of RBC-
NOX and RBC-NOS. 
Measurements of DAF-
FM or DCF associated 
cell fluorescence ( grey and white columns, 
respectively) and 
PS externalization 
(black columns) were performed after a 2 h and 24h incubation, 
respectively, in RBCs 
treated with TRIOL (2 
µM) or 7-KC (7 µM) or both preceded by 1 h pre-treatment in the absence or in the presence of DPI or 
L-NAME or both. Values are the mean ±SD of three separate experiments carried out in duplicate. Within 
homologue determinations, values with different letters are significantly different (P<0.0001) (one-way 
Anova associated with Bonferroni’s post test).
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